Lamivudine (3TC) in Tanzania: NEMLIT level, who can prescribe it and STG references

Lamivudine (3TC) is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level A (dispensary). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 8 or more sections.

Last updated

Prescribe on DukadawaRxAsk DukadawaRx AI

New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.

Is lamivudine (3TC) available on the DukaDawa pharmacy network?

Not yet. Lamivudine (3TC) is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.

Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.

Is lamivudine (3TC) on the NEMLIT, and who can prescribe it?

Yes. Lamivudine (3TC) is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level A (dispensary). At level A it may be prescribed by specialists, medical officers, dental officers, assistant medical officers, clinical officers and assistant clinical officers.

Level
A (dispensary)
Category
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (Anti-Infective Medicines)
Listed forms
Oral Liquid 50mg/mL; Tablet: 150mg
Page
NEMLIT, p. 10
Who may prescribe at each NEMLIT level (STG/NEMLIT 7th edition, Part I, Table 1). Levels listed for this medicine are highlighted.
LevelFacilityWho may prescribe
A (listed)DispensarySpecialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer
BHealth centreSpecialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer
CCouncil or district hospitalSpecialist, Medical Officer, Dental Officer, Assistant Medical Officer
DRegional referral hospitalSpecialist, Medical Officer, Dental Officer
SZonal, special and national hospitalsSpecialist

A medicine is listed from the lowest facility level where it should be available.

Where is lamivudine (3TC) in the Standard Treatment Guidelines?

The Standard Treatment Guidelines (7th edition, 2026) mention lamivudine (3TC) in 8 or more sections, most often section 10.5.1.1 Disorders of The Liver and Biliary Tract > Hepatitis > Viral Hepatitis (p. 246). See the STG for treatment details.

  • 10.5.1.1 Disorders of The Liver and Biliary Tract > Hepatitis > Viral Hepatitis, p. 246
  • 6.1.7 Management of Adult and Adolescent Living with HIV with Antiretroviral Therapy > Maternal HIV Care and Treatment, p. 137
  • 6.1.8 Management of Adult and Adolescent Living with HIV with Antiretroviral Therapy > Second-line ART in Adults and Adolescents, p. 137
  • 6.1.9 Management of Adult and Adolescent Living with HIV with Antiretroviral Therapy > Third-line Antiretroviral Therapy, p. 138
  • 6.1.10 Management of Adult and Adolescent Living with HIV with Antiretroviral Therapy > Changing Antiretroviral Therapy, p. 138
  • 6.2 Monitoring Patients on Antiretroviral Therapy, p. 144
  • 6.6.2 HIV Prevention > Pre-Exposure Prophylaxis (PrEP), p. 158
  • 8.7.3 Spinal Cord and Peripheral Nerve Disorders > Peripheral Neuropathy, p. 188

Sections that mention Lamivudine (3TC), most mentions first. Positions only: see the STG for treatment details.

Related medicines

All nucleoside/nucleotide reverse transcriptase inhibitors on the NEMLIT

Sources

  • Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania

Page last updated

STG positions are section numbers and printed page numbers only.

This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.

For licensed prescribers and pharmacists. Not medical advice. Check the Standard Treatment Guidelines before prescribing.